Heterozygous loss-of-function SCN1A mutations cause Dravet syndrome, an epileptic encephalopathy of infancy that exhibits variable clinical severity. We utilized a heterozygous Scn1a knockout (Scn1a
Heterozygous loss-of-function SCN1A mutations cause Dravet syndrome, an epileptic encephalopathy of infancy that exhibits variable clinical severity. We utilized a heterozygous Scn1a knockout (Scn1a
) mouse model of Dravet syndrome to investigate the basis for phenotype variability. These animals exhibit strain-dependent seizure severity and survival. Scn1a +/− mice on strain 129S6/SvEvTac (129.Scn1a
) have no overt phenotype and normal survival compared with Scn1a +/− mice bred to C57BL/6J (F1.Scn1a
) that have severe epilepsy and premature lethality. We tested the hypothesis that strain differences in sodium current (I Na ) density in hippocampal neurons contribute to these divergent phenotypes. Whole-cell voltage-clamp recording was performed on acutely-dissociated hippocampal neurons from postnatal days 21-24 (P21-24) 129.Scn1a +/− or F1.Scn1a +/− mice and wild-type littermates. I Na density was lower in GABAergic interneurons from F1.Scn1a +/− mice compared to wild-type littermates, while on the 129 strain there was no difference in GABAergic interneuron I Na density between 129.Scn1a +/− mice and wild-type littermate controls. By contrast, I Na density was elevated in pyramidal neurons from both 129.Scn1a +/− and F1.Scn1a +/− mice, and was correlated with more frequent spontaneous action potential firing in these neurons, as well as more sustained firing in F1.Scn1a +/− neurons. We also observed age-dependent differences in pyramidal neuron I Na density between wild-type and Scn1a +/− animals. We conclude that preserved I Na density in GABAergic interneurons contributes to the milder phenotype of 129.Scn1a +/− mice. Furthermore, elevated I Na density in excitatory pyramidal neu-
Introduction
Idiopathic epilepsies are a group of clinically diverse disorders with a strong genetic component to their pathogenesis. Although most epilepsies exhibit complex inheritance, some result from single gene mutations. Mutations in genes encoding neuronal voltage-gated sodium channels (Na V ) result in genetic epilepsies with overlapping clinical characteristics but divergent clinical severity (Meisler and Kearney, 2005) . Mutation of SCN1A, encoding the pore-forming subunit Na V 1.1, is the most commonly discovered cause of monogenic epilepsies (Catterall et al., 2010) . More than 800 heterozygous SCN1A epilepsyassociated mutations have been identified, with more than 70% occurring in patients with Dravet syndrome (DS), also known as severe myoclonic epilepsy of infancy (Claes et al., 2009; Lossin, 2009 ). While DS is typically characterized by seizure onset in the first year of life with an ensuing epileptic encephalopathy consisting of cognitive, behavioral, and motor impairments, the severity of its presentation and progression can be variable (Brunklaus et al., 2012; Zuberi et al., 2011) . However, it remains unclear why individuals bearing the same heterozygous SCN1A mutation exhibit divergent seizure phenotypes, even within the same family (Goldberg-Stern et al., 2013; Kimura et al., 2005; PinedaTrujillo et al., 2005) .
Genetic modifiers may contribute to the variable expressivity of SCN1A mutations in DS patients and this notion is further suggested by investigations of Scn1a knockout (Scn1a +/− ) and Scn1a-R1407X knock-in mouse models of DS (Miller et al., 2013; Ogiwara et al., 2007; Yu et al., 2006) . Heterozygous DS mice display spontaneous seizures and premature death as well as cognitive and motor impairments Available online on ScienceDirect (www.sciencedirect.com). 1 These authors contributed equally to this work.
